Macrobiome Therapeutics Pty Ltd is a company harnessing the therapeutic potential of hookworms and other parasitic helminths to develop drugs for the treatment of chronic wounds and autoimmune and metabolic diseases. The company is based in tropical North Queensland, Australia, an area of enormous biodiversity. Macrobiome Therapeutics was founded by Professor Alex Loukas and Dr Paul Giacomin of the Australian Institute of Tropical Health and Medicine at James Cook University, and brings together a number of leading international medical research teams to develop novel therapeutics for chronic diseases with limited treatment options, such as IBD, T2D, and non-healing wounds.